Gonadorelin Completed Phase 2 Trials for Highly Endocrine Responsive Operable Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03397537Neoadjuvant Endocrine Therapy in Breast Cancer